These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 13785770)
21. Edathamil (EDTA) therapy of interstitial calcinosis. LECKERT JT; MCHARDY GG; MCHARDY RJ South Med J; 1960 Jun; 53():728-31. PubMed ID: 14415074 [No Abstract] [Full Text] [Related]
22. Scleroderma (acrosclerosis). II. Tryptophan metabolism before and during treatment by Chelaton (EDTA). PRICE JM; BROWN RR; RUKAVINA JG; MENDELSON C; JOHNSON SA J Invest Dermatol; 1957 Oct; 29(4):289-98. PubMed ID: 13491892 [No Abstract] [Full Text] [Related]
23. Scleroderma (acrosclerosis). I. Treatment of three cases of the non-calcific variety by Chelation (EDTA). RUKAVINA JG; MENDELSON C; PRICE JM; BROWN RR; JOHNSON SA J Invest Dermatol; 1957 Oct; 29(4):273-88. PubMed ID: 13491891 [No Abstract] [Full Text] [Related]
25. [FURTHER OBSERVATIONS ON THE ZINC METABOLISM IN DIABETES MELLITUS]. CONSTAM GR; LEEMANN W; ALMASY F; CONSTAM AG Schweiz Med Wochenschr; 1964 Aug; 94():1104-9. PubMed ID: 14243607 [No Abstract] [Full Text] [Related]
26. [Experiences with ultrasonics in the therapy of skin diseases, with a contribution to the morphology of reactive changes in scleroderma]. KOCH R Strahlentherapie; 1955 Nov; 98(3):481-93. PubMed ID: 13298870 [No Abstract] [Full Text] [Related]
27. [Calcinosis cutis in scleroderma circumscriptum]. MATNER T Z Haut Geschlechtskr; 1962 Jul; 33():8-13. PubMed ID: 14471190 [No Abstract] [Full Text] [Related]
28. Treatment of calcinosis cutis in systemic sclerosis and dermatomyositis: A review of the literature. Traineau H; Aggarwal R; Monfort JB; Senet P; Oddis CV; Chizzolini C; Barbaud A; Francès C; Arnaud L; Chasset F J Am Acad Dermatol; 2020 Feb; 82(2):317-325. PubMed ID: 31302187 [TBL] [Abstract][Full Text] [Related]
29. Remodelling of calcinosis cutis in a patient with scleroderma overlap syndrome. Dittmer MR; Ogawa-Momohara M; Muro Y; Kono M; Akiyama M J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):e20-e21. PubMed ID: 31407385 [No Abstract] [Full Text] [Related]
31. Systemic sclerosis. Fourteen cases treated with chelation (disodium EDTA) and/or pyridoxine, with comments on the possible role of altered tryptophan metabolism in pathogenesis. BIRK RE; RUPE CE Henry Ford Hosp Med Bull; 1962 Dec; 10():523-53. PubMed ID: 13968436 [No Abstract] [Full Text] [Related]
32. [Scleroderma and calcinosis cutis with oesophageal changes and liver damage]. NIELSEN JP Nord Med; 1947 May; 34(21):1203-5. PubMed ID: 18896286 [No Abstract] [Full Text] [Related]
33. [Cutaneomucous aspects of scleroderma]. Texier L; Rommel A Ann Med Interne (Paris); 1984; 135(8):580-3. PubMed ID: 6529052 [No Abstract] [Full Text] [Related]
34. Calcinosis cutis requiring sculpturing in scleroderma. Sengezer M; Türegün M; Tip GA Plast Reconstr Surg; 1996 Dec; 98(7):1319-21. PubMed ID: 8942931 [No Abstract] [Full Text] [Related]
39. Doubly refractile lipoid bodies in the urinary sediment of a patient with progressive scleroderma and calcinosis. ROSEN GM; CARP L; VERNON CM N Y State J Med; 1951 May; 51(9):1183-4. PubMed ID: 14843406 [No Abstract] [Full Text] [Related]
40. [Calcification in scleroderma (contribution to the so-called Thiebierge-Weissenbach syndrome)]. Kolár J; Drugová B; Stáva Z Sb Lek; 1971 Oct; 73(10):258-63. PubMed ID: 5137493 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]